Right-handed And Left-handed People Do Not See The Same Bright Side Of Things, According To Several Studies
Despite the almost universal association of the right with life, right, positive and good things, and the left with death, inadequacy, negative and bad things, recent researches show that left-handed people hold the opposite association. Thus, left-handers become a critical case in which conceptual associations, result of a sensory-motor experience, and those that rely on linguistic and cultural uses, are contradictory. A sensory-motor experience in itself is capable of creating abstract conceptual associations. These are the conclusions derived from various studies compiled by professor Julio Santiago de Torres, from the Department of Experimental Psychology and Behavioural Physiology at the University of Granada, who has conducted a bibliographic review on the subject, published in Ciencia Cognitiva: Revista ElectrÃ nica de Divulgacion.
Following an argument or a particularly heated discussion with our partner, they may remember details of the conversation very differently than we do. This may lead to even more arguments, as we try to convince the other that our recollection of the argument is more correct then theirs. It can be frustrating when our partners remember things differently than we do, but according to new research from Psychological Science, a journal of the Association for Psychological Science, they are not trying to be difficult, but personality may affect how they (and we) remember relationship events (such as discussions). Research has shown that our specific attachment style (that is, how anxious or avoidant we are in relationships) may affect many facets of our relationships.
People being treated for schizophrenia are more likely than the general population to have encounters with the criminal justice system in the US. A study published in the open access journal BMC Psychiatry has shown that schizophrenia patients' involvement with the criminal justice system is primarily driven by their being victims of crime and that the average annual per-patient cost of involvement with the criminal justice system was $1429. Haya Ascher-Svanum led a team of researchers from Eli Lilly and Company, USA, who used data from a study of around 600 people with schizophrenia to estimate the prevalence and cost of involvement with the criminal justice system.
The Kentucky Senate on Monday voted 32-4 to approve a bill (SB 38) that would require physicians to show women an ultrasound and describe "the dimensions of the embryo or fetus and the presence of external members and internal organs, if present and viewable, " the Louisville Courier-Journal reports (Gerth, Louisville Courier-Journal, 1/25). State Sen. Elizabeth Tori (R), lead sponsor of the bill, said it would not prohibit a woman from averting her eyes from the image ( AP/Kentucky Enquirer, 1/26). The bill also would require physicians or someone they designate to meet with the patient in person at least 24 hours before the procedure to explain the process.
ADHD, or attention-deficit/hyperactivity disorder, is among the costliest of behavioral disorders. Its combination of inattention, impulsivity and hyperactivity leads to accidental injuries, school failure, substance abuse, antisocial behavior and more. Yet despite nearly a century of study, the disorder's roots remain mysterious. Much of modern ADHD research has focused on heritability of the condition, and indeed evidence suggests that genes may account for as much as 70 percent of hyperactivity and inattention in children. But that leaves 30 percent unexplained, so recently the focus has shifted to the environment. What is it that triggers an underlying susceptibility and changes it into a full-blown disorder?
Omeros Announces National Institute On Drug Abuse's Support For Phase 2 Clinical Study In Addiction Program
Omeros Corporation (Nasdaq: OMER) announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company's Addiction program. NIDA will fund substantially all of the costs of a Phase 2 clinical study to be conducted by New York State Psychiatric Institute researchers. In its Addiction program, Omeros is developing proprietary compositions that include peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonists for the prevention and treatment of addiction to substances of abuse, such as opioids, nicotine and alcohol, as well as other compulsive behaviors, including eating disorders. The Company's data from earlier European pilot clinical studies and animal models of addiction have demonstrated a previously unknown link between PPAR-gamma and addiction disorders.